Latest filing published 28 Apr 2021 for Revolution Medicines, Inc., €883k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter Svennilson: trading record in brief
Peter Svennilson is a declared insider at 7 companies; the most frequent names are NGM Biopharmaceuticals Inc, Revolution Medicines, Inc. and Immune Design Corp. The record holds 109 filings, for trades running from 29 July 2014 to 28 April 2021.
Market trades split into 70 purchases (€71.5M) and 20 sales (€97.4M). The net balance comes to €25.9M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. 2021 to date brings no purchases and 16 sales.
The median purchase comes to €193k. 69 out of 69 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 28 April 2021: an open-market sale of €883k, in Revolution Medicines, Inc. The clock since the last published purchase (9 April 2020) now reads 2,404 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter Svennilson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,883 shares@ US$42.8510.1% of flowCommon StockSEC:0000899243-21-017254:0
- 28,101 shares@ US$42.8511.4% of flowCommon StockSEC:0000899243-21-017254:1
- 10,955 shares@ US$42.654.4% of flowCommon StockSEC:0000899243-21-017254:2
- 12,371 shares@ US$42.655.0% of flowCommon StockSEC:0000899243-21-017254:3
- 47 shares@ US$42.500.0% of flowCommon StockSEC:0000899243-21-017254:4
- 53 shares@ US$42.500.0% of flowCommon StockSEC:0000899243-21-017254:5
- 21,710 shares@ US$44.809.3% of flowCommon StockSEC:0000899243-21-015537:0
- 24,518 shares@ US$44.8010.5% of flowCommon StockSEC:0000899243-21-015537:1
- 11,600 shares@ US$43.834.9% of flowCommon StockSEC:0000899243-21-015537:2
- 13,101 shares@ US$43.835.5% of flowCommon StockSEC:0000899243-21-015537:3
- 8,554 shares@ US$46.653.9% of flowCommon StockSEC:0000899243-21-015320:0
- 9,661 shares@ US$46.654.4% of flowCommon StockSEC:0000899243-21-015320:1
- 18,551 shares@ US$48.068.6% of flowCommon StockSEC:0000899243-21-015320:2
- 20,949 shares@ US$48.069.7% of flowCommon StockSEC:0000899243-21-015320:3
- 13,128 shares@ US$45.605.8% of flowCommon StockSEC:0000899243-21-015320:4
- 14,825 shares@ US$45.606.5% of flowCommon StockSEC:0000899243-21-015320:5
- 469,635 shares0Common StockSEC:0000899243-20-033611:0
- 22,011 shares0Common StockSEC:0000899243-20-033611:1
- 530,365 shares0Common StockSEC:0000899243-20-033611:2
- 24,857 shares0Common StockSEC:0000899243-20-033611:3
- 46,868 shares0Common StockSEC:0000899243-20-033611:4
- 46 shares0Common StockSEC:0000899243-20-033611:5
- 13,068 shares0Common StockSEC:0000899243-20-033611:6
- 952,023 shares@ US$36.4047.0% of flowCommon StockSEC:0000899243-20-031482:0
- 1,075,133 shares@ US$36.4053.0% of flowCommon StockSEC:0000899243-20-031482:1
25 of 45 declarations
